## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-06-21T13:35:56.427Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Neuro Toolkit"
developer_entity: "Kent Ellington"
bundle_id: "NeuroToolkit"
app_store_id: "350656519"
google_play_id: "com.fuego.neuro"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-04-01"
report_date: "2026-06-21"
last_verified: "2026-06-21"
report_version: "4.00"
total_reviews: 16
overall_rating: 4.69
sentiment: "Thrilled"
sentiment_score: 85
confidence: "medium"
confidence_score: 0.5
top_praise_theme: "Functional design for clinical use"
top_complaint_theme: "Lack of updates for newer criteria"
top_request_theme: "Expanded clinical scale library"
review_sample_size: 16
data_age_days: 0
intelligence_version: 3
competitor_count: 4
tags: ["medical", "paid", "thrilled sentiment", "mobile app", "app review", "app analysis", "neurology", "practitioners", "neurosurgery"]
canonical_url: "https://marlvel.ai/intel-report/medical/neurotoolkit"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Neuro Toolkit App Audit

## TL;DR {#tldr}

- **Category**: Medical · Paid
- **Signal**: Rating 4.69 · Sentiment Thrilled
- **Recent focus**: Lack of updates for newer criteria (top complaint) · Functional design for clinical use (top praise) · Expanded clinical scale library (top request)

> **TL;DR:** Neuro Toolkit is a medical app by Kent Ellington, rated 4.69/5 by 16 users, with Thrilled user sentiment (85/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Neuro Toolkit maintains Thrilled user sentiment (4.69/5 from 16 reviews), with users consistently praising functional design for clinical use.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.69/5 (16 reviews) |
| **User Mood** | Thrilled |
| **Category** | Medical |
| **Developer** | Kent Ellington |
| **Pricing** | Paid |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.5/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Kent Ellington
- **Category:** Medical
- **Target Audience:** Neurology practitioners and neurosurgery residents requiring rapid access to clinical grading scales and diagnostic criteria.
- **Platforms:** iOS & Android
- **Version Audited:** 4.00
- **Audit Date:** 2026-06-21
- **Signal Count:** 16 reviews analyzed
- **Confidence:** Medium (0.5/1.0)
- **App Store ID (iOS):** 350656519
- **Bundle ID:** NeuroToolkit
- **Google Play ID:** com.fuego.neuro
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-06-21
- **Short Description:** Functional Gum and Mints | Energy and Focus

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Neuro Toolkit is a clinical reference app for neurology practitioners, providing grading scales and diagnostic criteria on iOS and Android.
**Why users hire it:** Clinicians hire the app to reduce time-to-information during patient rounds, replacing manual lookup with a consolidated, offline-accessible digital tool.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Neurology Grading Scales:** Collection of clinical grading scales for stroke, subarachnoid hemorrhage, and coma, including prognosis data.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Result Export:** Email functionality for clinical results in text or password-protected PDF format for office charts.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] Clinical Tools:** Integrated flashlight with pupil sizes and tuning fork functionality for physical exams.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Neuro Toolkit holds a top 50 paid position in the US Medical category, but its grossing rank lags behind, signaling that the one-time purchase model fails to capture the long-term value of the professional user base.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase at $6.99
- **Price:** iOS: $6.99
- **Analysis:** Paid model at $6.99 price point targets professional medical users with a one-time acquisition cost.

<!-- section:sentiment -->
## 🟢 User Sentiment (Medium Confidence: 16 reviews) {#user-sentiment}
- **Overall Rating:** 4.69/5
- **Platform Split:** iOS 4.7/5 (16 ratings)
- **Overall Sentiment:** Thrilled

### Top Praises
- **Functional design for clinical use**

### Top Complaints (Impact Areas)
- **Lack of updates for newer criteria**

### Top Requests (What Users Want)
- **Expanded clinical scale library**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Prognosis-integrated clinical scales function as a high-utility reference moat
- Offline-first architecture ensures reliability in hospital environments

**Critical Frictions:**
- One-time $6.99 purchase model limits recurring revenue
- Lack of Android-iOS feature parity creates fragmented user experience

**Growth Levers:**
- Subscription-based premium tier for real-time clinical guideline updates
- Integration with electronic health record systems via API

**Market Threats:**
- High-frequency update cadence of Vargo Anesthesia Mega App
- Consolidation of clinical tools into physician networking platforms

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

Neuro Toolkit has refined its competitive positioning by identifying its one-time purchase model as a primary weakness against subscription-based rivals, while expanding its clinical library.

**Overall trend**: Mixed
**Compared at**: 2026-06-21

### High-impact changes
- **[Shifted] Revenue Model Stagnation** (pricing) — The app remains at a $6.99 one-time purchase price point, which is now identified as a limitation for funding the continuous updates required to maintain clinical relevance.
- **[Improved] Core Feature Repositioning** (features) — Neurology Grading Scales and Result Export features were upgraded from 'standard' to 'differentiator' status.

### Medium-impact changes
- **[Added] Clinical Library Expansion** (features) — Added in-app search, 2024 McDonald Criteria, and MGADL/INCAT scales to the feature set.
- **[Declined] Emergence of Update-Related Complaints** (sentiment) — New user complaint theme identified regarding the lack of frequent updates for evolving clinical guidelines.

<!-- section:momentum -->
## App Momentum (Steady) {#momentum}

- Implemented in-app search function.
- Updated to 2024 McDonald Criteria.
- Added MGADL and INCAT scales.

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Neuro Toolkit is a market-leading medical app that is a paid app.
With a 4.69/5 rating from 16 reviews, it delivers strong user satisfaction.

<!-- speakable-start -->
> **Bottom Line:** Neuro Toolkit maintains a strong reputation for clinical utility, but its one-time purchase model leaves it exposed to subscription-based rivals, so the PM should pivot to a recurring revenue model to fund the update cadence required to defend the category lead.
<!-- speakable-end -->

**Best for:** Neurology practitioners and neurosurgery residents requiring rapid access to clinical grading scales and diagnostic criteria.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Pivot to subscription model for clinical guideline updates because the current one-time purchase limits recurring revenue → increase lifetime value — *The current $6.99 one-time price point fails to capture long-term value compared to subscription-based medical competitors.* _(trade-off: deprioritize Pause the development of new physical exam tools — clinical utility is already high.)_
- [ ] [INVEST] [MEDIUM IMPACT] Ship feature parity updates to Android because the current version gap creates a fragmented experience → improve Android rating baseline — *The Android build lacks the depth of the iOS version, creating a potential churn risk for non-iOS clinicians.* _(trade-off: deprioritize Deprioritize the addition of new, niche grading scales — current library is sufficient for most users.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Real-time clinical guideline updates (available in Vargo Anesthesia Mega App but absent here)
- Secure physician-to-physician communication (available in Doximity but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Mixed

The medical reference market is consolidating around platforms that offer continuous updates and workflow integration, leaving static, one-time purchase tools exposed. Neuro Toolkit must transition to a recurring revenue model to sustain the update cadence necessary to compete with high-velocity rivals like Vargo Anesthesia.

- 🔴 The one-time purchase model limits the capital available for the high-frequency updates required to keep clinical data current, which risks long-term user attrition.
- 🟢 The integration of prognosis data into clinical scales provides a unique utility that keeps the app relevant for daily clinical rounds.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.69/5 |
| Total Reviews | 16 |
| Sentiment | Thrilled (85/100) |
| Confidence | Medium |
| Pricing Model | Paid |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Neuro Toolkit** (this app) | 4.69/5 | Thrilled | Kent Ellington |
| [VA: Health and Benefits](https://marlvel.ai/intel-report/medical/gov-va-vamobileapp) | 4.8/5 | N/A | US Department of Veterans Affairs (VA) |
| [Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) | 4.8/5 | N/A | Doximity |
| [Vargo Anesthesia Mega App](https://marlvel.ai/intel-report/medical/com-insertnamehere-vargomasterapp) | 4.7/5 | N/A | Vargo Anesthesia Inc |
| [Eka: Health AI, ABHA, Records](https://marlvel.ai/intel-report/medical/com-orbi-eka-care) | 4.6/5 | N/A | Orbi Health private limited |
| [Move On with AJ](https://marlvel.ai/intel-report/medical/move-on-with-aj) | 4.3/5 | Excited | Universal Relaxation Ltd |

## Company Profile
- **Developer:** Kent Ellington
- **Website:** [https://neurotoolkit.blogspot.com](https://neurotoolkit.blogspot.com)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/neuro-toolkit/id350656519?uo=2)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.fuego.neuro&hl=en&gl=us)
- **Dev Site:** [Official Website](https://neurotoolkit.blogspot.com)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*VA: Health and Benefits*](https://marlvel.ai/intel-report/medical/gov-va-vamobileapp) (US Department of Veterans Affairs (VA)) — 4.8/5 Rating | N/A Sentiment
- [*Doximity*](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) (Doximity) — 4.8/5 Rating | N/A Sentiment
- [*Vargo Anesthesia Mega App*](https://marlvel.ai/intel-report/medical/com-insertnamehere-vargomasterapp) (Vargo Anesthesia Inc) — 4.7/5 Rating | N/A Sentiment
- [*Eka: Health AI, ABHA, Records*](https://marlvel.ai/intel-report/medical/com-orbi-eka-care) (Orbi Health private limited) — 4.6/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment
- [*Dario Health*](https://marlvel.ai/intel-report/medical/dario-health) (LabStyle Innovation Ltd) — 4.8/5 Rating | Negative Sentiment
- [*Mobile Verification Roche*](https://marlvel.ai/intel-report/medical/com-roche-itunes-mvroche) (F. Hoffmann-La Roche) — N/A Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 16
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/neurotoolkit)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.